The text starts here.

News Release

Information in the news releases is current on the date of the announcement, but is subject to change without prior notice.

1998 Release

December 1, 1998 Eisai's German Subsidiary Begins Sales of PARIET, a Proton Pump Inhibitor
November 30, 1998 Eisai Launches "TAMBOCOR Injection 50mg" an Antiarrthymic Treatment
November 24, 1998 Eisai Announces Production & Shipment Commencement of ARICEPT, an Alzheimer's Disease Treatment, From US Manufacturing Facility
November 10, 1998 Eisai Announces Non-Consolidated Semiannual Financial Results for the Fiscal Year Ending March 31, 1999
November 10, 1998 Notice of Consolidated Business Results Forecast Revision For the Fiscal Year Ending March 1999
October 22, 1998 Toyama Chemical & Eisai Sign Co-development Licensing Agreement in Japan for Toyama's T-614, a New Treatment for Rheumatoid Arthritis Currently Under Development in Japan and in Foreign Countries
October 7, 1998 Eisai's Proton Pump Inhibitor Receives Agreement For Approval in All European Union Member States
October 2, 1998 Notice of Valuation Loss on Listed Marketable Securities and Business Results Forecast Revision
September 30, 1998 Patent Registration Completed For SELBEX Gastritis Use Treatment
August 6, 1998 Eisai Submits New Drug Application For Donepezil Hydrochloride (U.S./Western Europe Registered Trademark: ARICEPT) to the Japanese Ministry of Health and Welfare
August 5, 1998 Eisai Launches "CHOCOLA EC", an Over the Counter Product, With Natural Type Vitamin E & Vitamin C
June 22, 1998 Eisai Launches ARICEPT, an Alzheimer's Disease Treatment, in Asia
June 15, 1998 Eisai Launches Myocardial Infarction Treatment "CLEACTOR"
June 2, 1998 Eisai and Toprak Sign Agreement for Marketing of Pharmaceuticals in Turkey
May 21, 1998 Eisai Announces Non-Consolidated and Consolidated Financial Results for the Fiscal Year Ended March 31, 1998
May 21, 1998 Eisai Announces Proposal for Partial Amendment to the Articles of Incorporation to Enable Purchases of Eisai Stock
May 21, 1998 Eisai Withdraws New Drug Application for E1077, an Antibiotic
May 13, 1998 Eisai Receives Marketing Authorization For PARIET (rabeprazole sodium), A Proton Pump Inhibitor, From the U.K. Medicines Control Agency.
April 1, 1998 Eisai Submits NDA For Aciphex - New Drug Developed to Treat Gastroesophageal Reflux Disease (GERD) and Ulcers
March 13, 1998 Eisai Announces Launch of ARICEPT (donepezil hydrochloride), New Treatment for Alzheimer's Disease in France
February 27, 1998 Notice of Dividend Payment for the Year Ending March 1998 (86th Fiscal Term)
January 8, 1998 Eisai and Knoll AG Announce A License Agreement For A New Anti-Obesity Drug in Japan

Back to Top